![CT-707, a novel FAK inhibitor, synergizes with Cabozantinib to suppress hepatocellular carcinoma by blocking Cabozantinib-induced FAK activation]()
CT-707, a novel FAK inhibitor, synergizes with Cabozantinib to suppress hepatocellular carcinoma by blocking Cabozantinib-induced FAK activationWang, D.-D.; Chen, Y.; Chen, Z.-b.; Yan, F.-J.; Dai, X.-Y.; Ying, M.-d.; Cao, J.; Ma, J.; Luo, P.; Han, Y.-X.; Peng, Y.; Sun, Y.; Zhang, H.; He, Q.-j.; Yang, B.; Zhu, H. · Molecular Cancer Therapeutics · 2016